Navigation Links
VirtualScopics Reports First Quarter 2013 Results
Date:5/15/2013

the risk of cancellation or delay of customer contracts or specifically as it relates to contact awards, the risk that they may not get signed.  Other risks include the company's dependence on its largest customers and risks of contract performance, protection of our intellectual property and the risks of infringement of the intellectual property rights of others. All forward-looking statements speak only as of the date of this press release and the Company undertakes no obligation to update such forward-looking statements.

 

-Financial tables to follow-CONTACTS: Investor Relations:Company Contact:Tim RyanMolly HendersonThe Shoreham GroupChief Business and Financial Officer, Sr. Vice President80 Eighth Ave, Ste 1107500 Linden OaksNew York, NYRochester, New York 14625+1 212 242 7777 Direct+1 585 249.6231tryan@shorehamgroupllc.com   

 VirtualScopics, Inc. and SubsidiaryCondensed Consolidated Statements of Operations (unaudited)For the Three Months Ended March 31,20132012Revenues$
2,282,831$
3,293,659Reimbursement revenues249,756408,500Total revenues2,532,5873,702,159Cost of revenues1,497,5391,882,745Cost of reimbursement revenues249,756408,500Total cost of services1,747,2952,291,245Gross profit785,2921,410,914Operating expensesResearch and development433,846356,326Sales and marketing354,609331,072General and administrative890,035654,741Stock-based compensation expense127,945175,936Depreciation and amortization96,313111,619Total operating expenses1,902,7481,629,694Operating loss(1,117,456)(218,780)Other income (expense)Interest income1,010416Other expense(1,372)(268)Unrealized gain (loss) on change in fair value of derivative liabilities

4,870(394,912)Total other income (expense)4,508(394,764)Net loss(1,112,948)(613,544)Preferred stock dividends42,00012,000Net loss available to common stockholders$
(1,154,948)$
(625,544)Basic and diluted net loss per
'/>"/>

SOURCE VirtualScopics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. VirtualScopics Schedules Second Quarter 2012 Earnings Announcement
2. VirtualScopics Reports 2nd Quarter 2012 Results
3. VirtualScopics Announces Receipt of Notice from Nasdaq
4. VirtualScopics to Present at the Upcoming Rodman & Renshaw Annual Global Investment Conference
5. VirtualScopics Receives Issuance of Influential Patent in Canada
6. VirtualScopics Reports 3rd Quarter 2012 Results
7. VirtualScopics Schedules Fourth Quarter and Full Year 2012 Earnings Announcement
8. VirtualScopics Reports Fourth-Quarter and Full-Year 2012 Results
9. VirtualScopics Receives Additional Time to Regain Compliance with Nasdaq
10. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
11. Sigma-Aldrich (NASDAQ: SIAL) Reports Q1 2012 Diluted EPS of $0.96, With Diluted Adjusted EPS of $0.99. Sales Increase 5% for Q1 2012. Full Year 2012 Diluted Adjusted EPS Outlook of $3.90 to $4.05 Reaffirmed.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)...  According to Millennium Research Group (MRG), the global ... the United States and European transcatheter ... moderately through 2022, with embolization particles representing one ... in drug-eluting beads (DEBs) and radioembolization spheres in ...
(Date:1/15/2014)... , Jan. 15, 2014 ... research report is available in its ... Markets and Technologies for Advanced Drug ... of Administration ...
(Date:1/14/2014)... InformEx, North America,s leading business ... hold the 30 th edition of its annual conference ... from January 21-24. (Logo: http://photos.prnewswire.com/prnh/20131028/NY05330LOGO-a ) ... chemical and specialty chemical companies will take part in the ...
Breaking Medicine Technology:US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 2US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 2Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 4Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 6Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 7Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 8Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 9Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 10Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 11Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 12Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 13Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 14Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 15Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 16Media Advisory: InformEx 2014 Events & Speaker Lineup for 30th Edition Conference in Miami Beach 2
(Date:4/17/2014)... the April issue of Immunity , Kevin J. ... Research, says it,s time to take a fresh look ... sepsis, which kills millions worldwide every year, including more ... into the bloodstream to fight an injury or infection ... maintaining good health without inflammation, wounds and infections ...
(Date:4/17/2014)... A Northwestern University synthetic biology team has created ... create programmable therapeutics that could travel the body ... disease. , Engineering cell-based, biological devices that monitor ... in clinical synthetic biology. However, no existing technology ... a patient,s physiological state and respond in a ...
(Date:4/17/2014)... Il. (April 17, 2014) Doctors who treat ... called lymphangioleiomyomatosis (LAM) can face an agonizing treatment ... of the disease and help relieve shortness of ... transplants, and sirolimus can cause potentially fatal complications ... pulmonologist Dr. Daniel Dilling, medical director of Loyola ...
(Date:4/17/2014)... NEW YORK, NY (April 16, 2014) The cause ... but a new study proposes that neurons may be ... own immune system, similar to the way autoimmune diseases ... attack the body,s cells. The study was published April ... is a new, and likely controversial, idea in Parkinson,s ...
(Date:4/17/2014)... 2014 By discovering a new mechanism that allows ... researchers at UC Irvine and the Salk Institute have ... or prevent stroke-induced brain damage. , A complex and ... death and primary reason for disability in the U.S. ... and lets blood-borne material into the brain, causing the ...
Breaking Medicine News(10 mins):Health News:Feinstein Institute researcher publishes new perspective on sepsis 2Health News:Building 'smart' cell-based therapies 2Health News:Patients with rare lung disease face agonizing treatment dilemma 2Health News:Patients with rare lung disease face agonizing treatment dilemma 3Health News:Is Parkinson's an autoimmune disease? 2Health News:Study IDs new cause of brain bleeding immediately after stroke 2
... new study led by Fox Chase Cancer Center radiation ... scores determined by pathologists at Fox Chase Cancer Center ... scores from referring institutions. She presented the new ... Society for Radiation Oncology on Monday, October 3. ...
... busy," and "too complicated." These are the typical excuses ... they fail to use online error-reporting systems designed to ... Johns Hopkins investigators found instead that the most common ... trouble and embarrassment. Investigators e-mailed an anonymous survey ...
... the parents of women with polycystic ovary syndrome (PCOS) are more ... a hormonal disorder affecting about 10% of women of reproductive age. ... women and a leading cause of infertility. The study shows ... form of cardiovascular disease, and almost twice as likely to have ...
... severe 2009 H1N1 influenza who developed respiratory failure and were ... blood had a lower rate of in-hospital death than similar ... study appearing in JAMA . The study is being ... European Society of Intensive Care Medicine meeting in Berlin. ...
... HealthDay Reporter , TUESDAY, Oct. 4 (HealthDay News) -- ... fare just as well if they are released the same day ... new research shows. "[Discharging patients the same day] wasn,t ... Rao, lead author of a study appearing in the Oct. 5 ...
... News) -- ,Raw sewage contains thousands of undiscovered viruses, ... study suggests. Viruses are everywhere, but only about ... this study, researchers looked for the genetic signatures of ... and Africa. They detected the signatures of 234 known ...
Cached Medicine News:Health News:Fox Chase Gleason scores better predict prostate cancer's recurrence after radiation 2Health News:Fox Chase Gleason scores better predict prostate cancer's recurrence after radiation 3Health News:Survey reveals reasons doctors avoid online error-reporting tools 2Health News:Oxygenating system associated with lower risk of death for H1N1 patients with respiratory failure 2Health News:Oxygenating system associated with lower risk of death for H1N1 patients with respiratory failure 3Health News:Overnight Stay May Not Be Necessary for Stenting: Study 2Health News:Overnight Stay May Not Be Necessary for Stenting: Study 3Health News:Raw Sewage a New Frontier for Scientists 2
PRINCIPLE: The QC-SLIDES™ are specifically designed microscope slides intended to be part of the quality control program to monitor microbiological stains and staining techniques....
... KWIK-QC Slides have a positive and negative ... inoculation. With these slides, perform QC and ... enhance their education and training programs by ... interpretation, all on one slide! KWIK-QC slides ...
Microbiology QC Slides come with one or two droplets of an air-dried and methanol-fixed microorganism, or a single smear containing a designated microorganism population....
... Well Plate Capability The Equalizer 384 ... Equalizerexpandable and equal tip spacing, choice of two ... In addition, this model allows you to evenly ... and accessing many gels and for use with ...
Medicine Products: